Pages

Wednesday, March 2, 2016

Ibrutinib rejected in England

Before the deafening calls for single payer health care overwhelm any thoughtful discussion about how to pay for crazy expensive medications, I thought this article highlights just how much autonomy is removed in such a system.

England Rejects Ibrutinib in CLL

While our system is definitely a broken mess, at least we can prescribe Ibrutinib without having a major fight with insurance in most cases.